63600793 — Imjudo (tremelimumab-actl) 300 Mg/15 Ml Sdv
$99,080
All-payer median here
$98,342
Cash / self-pay here
10
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.